NCT03043053View on ClinicalTrials.gov

The Effects of Oxytocin in Obese Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

May 20, 2022

Study Completion Date

July 7, 2022

Conditions
Obesity
Interventions
DRUG

oxytocin nasal spray

oxytocin intranasal spray

DRUG

Placebo

Placebo nasal spray

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT03043053 - The Effects of Oxytocin in Obese Adults | Biotech Hunter | Biotech Hunter